CRDMOs Redefining Drug Substance Development with Platform Technologies
The development of biopharmaceuticals is expanding at an unprecedented rate, as the industry now comprises around 20 percent of the global pharmaceutical marke...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.